Follicular Lymphoma Therapy
Data on follicular lymphoma therapy described by researchers at University of Modena
Published in Blood Weekly, August 30th, 2007
Researchers detail in "Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma," new data in follicular lymphoma. "The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with fludarabine and cyclophosphamide in patients with recurrent follicular lymphoma (FL). This study was a noncomparative, multicenter, phase II study," investigators in Modena, Italy report.
"Between March 2000 and December 2002, 54 patients with recurrent FL were enrolled in the FC+R trial. Patients received fludarabine at a dose of 25 mg/m2 and cyclophosphamide at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-08-30)
More Articles from Blood Weekly
- Eye Cancer
Immune deficiency linked to a type of eye cancer - Vascular Disease
Study begins to reveal clues to the cause and progression of sepsis - Bioengineering
HepaLife Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010 - Bioengineering
Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor - Biomedicine
18 Regional Associations Partner in Support of AdvaMed 2007, a New International Medtech Conference & Exhibition - Biomedicine
Bridgetech Opens Taiwan Office - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
